Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Author:
Affiliation:
1. School of Life Science and Technology, ShanghaiTech University, Shanghai, China
2. Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China
3. University of Chinese Academy of Sciences, Beijing, China
Abstract
Funder
National Natural Science Foundation of China
Publisher
eLife Sciences Publications, Ltd
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Link
https://cdn.elifesciences.org/articles/49020/elife-49020-v1.pdf
Reference50 articles.
1. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade;Ayers;Journal of Clinical Investigation,2017
2. Regulation of tumor growth by IFN-gamma in Cancer immunotherapy;Beatty;Immunologic Research,2001
3. Opposing functions of interferon coordinate adaptive and innate immune responses to Cancer immune checkpoint blockade;Benci;Cell,2019
4. The determinants of tumour immunogenicity;Blankenstein;Nature Reviews Cancer,2012
5. Analysis of 100,000 human Cancer genomes reveals the landscape of tumor mutational burden;Chalmers;Genome Medicine,2017
Cited by 209 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape;Biomedicine & Pharmacotherapy;2024-02
2. Association of an eight-gene signature prognosis model with tumor immunity in medulloblastoma;2024-01-22
3. DeepVelo: deep learning extends RNA velocity to multi-lineage systems with cell-specific kinetics;Genome Biology;2024-01-19
4. Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma;Journal of Pathology and Translational Medicine;2024-01-15
5. Integrated germline and somatic features reveal divergent immune pathways driving ICB response;2024-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3